ID
31873
Description
A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab; ODM derived from: https://clinicaltrials.gov/show/NCT00808210
Link
https://clinicaltrials.gov/show/NCT00808210
Keywords
Versions (1)
- 10/5/18 10/5/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
October 5, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Rheumatoid Arthritis NCT00808210
Eligibility Rheumatoid Arthritis NCT00808210
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Autoimmune Disease Rheumatic | Exception Rheumatoid Arthritis | Rheumatoid arthritis with systemic involvement
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004364
- UMLS CUI [1,2]
- C0035435
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0003873
- UMLS CUI [3]
- C0494896
Description
Inflammatory joint disease | Exception Rheumatoid Arthritis | Gout | Arthritis, Reactive | Arthritis, Psoriatic | Spondylarthropathy Seronegative | Lyme Disease | Systemic Autoimmune disease | Lupus Erythematosus, Systemic | Inflammatory Bowel Diseases | Scleroderma | Myositis | Mixed Connective Tissue Disease | Overlap syndrome
Data type
boolean
Alias
- UMLS CUI [1]
- C0683381
- UMLS CUI [2,1]
- C1705847
- UMLS CUI [2,2]
- C0003873
- UMLS CUI [3]
- C0018099
- UMLS CUI [4]
- C0085435
- UMLS CUI [5]
- C0003872
- UMLS CUI [6,1]
- C0949691
- UMLS CUI [6,2]
- C0521144
- UMLS CUI [7]
- C0024198
- UMLS CUI [8]
- C2895206
- UMLS CUI [9]
- C0024141
- UMLS CUI [10]
- C0021390
- UMLS CUI [11]
- C0011644
- UMLS CUI [12]
- C0027121
- UMLS CUI [13]
- C0026272
- UMLS CUI [14]
- C0410000
Description
Biological treatment Rheumatoid Arthritis | Investigational New Drugs | Exception Etanercept | Exception Adalimumab
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1531518
- UMLS CUI [1,2]
- C0003873
- UMLS CUI [2]
- C0013230
- UMLS CUI [3,1]
- C1705847
- UMLS CUI [3,2]
- C0717758
- UMLS CUI [4,1]
- C1705847
- UMLS CUI [4,2]
- C1122087
Description
Anti-TNF-alpha therapy Quantity
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0281481
- UMLS CUI [1,2]
- C1265611
Similar models
Eligibility Rheumatoid Arthritis NCT00808210
- StudyEvent: Eligibility
C0003873 (UMLS CUI [1,2])
C0029921 (UMLS CUI [2])
C1522438 (UMLS CUI [1,2])
C0560588 (UMLS CUI [1,3])
C1122087 (UMLS CUI [2,1])
C1522438 (UMLS CUI [2,2])
C0560588 (UMLS CUI [2,3])
C0205225 (UMLS CUI [1,2])
C1562242 (UMLS CUI [2,1])
C0205435 (UMLS CUI [2,2])
C1280519 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0035435 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0494896 (UMLS CUI [3])
C1705847 (UMLS CUI [2,1])
C0003873 (UMLS CUI [2,2])
C0018099 (UMLS CUI [3])
C0085435 (UMLS CUI [4])
C0003872 (UMLS CUI [5])
C0949691 (UMLS CUI [6,1])
C0521144 (UMLS CUI [6,2])
C0024198 (UMLS CUI [7])
C2895206 (UMLS CUI [8])
C0024141 (UMLS CUI [9])
C0021390 (UMLS CUI [10])
C0011644 (UMLS CUI [11])
C0027121 (UMLS CUI [12])
C0026272 (UMLS CUI [13])
C0410000 (UMLS CUI [14])
C0003873 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0717758 (UMLS CUI [3,2])
C1705847 (UMLS CUI [4,1])
C1122087 (UMLS CUI [4,2])
C1265611 (UMLS CUI [1,2])